INVESTORS & MEDIA

Canaccord Genuity 38th Annual Growth Conference

Aug 9, 2018 at 12:00 PM EDT


Additional Information

Chris Haqq, M.D., Ph.D., the Company's Executive Vice President of Research and Development and Chief Scientific Officer, will participate in a biotech immunotherapy panel discussion on Thursday, August 9th, 2018 at 12:00 p.m. EDT.  The conference will be held at the InterContinental Boston.